Objectives: Oxazolidinone resistance is a serious limitation in the treatment of MDR Enterococcus infections. Plasmid-mediated oxazolidinone resistance has been strongly linked to animals where the use of phenicols might co-select resistance to both antibiotic families. Our goal was to assess the diversity of genes conferring phenicol/oxazolidinone resistance among diverse enterococci and to characterize the optrA genetic environment.
Introduction
Resistance to oxazolidinones (linezolid and tedizolid) represents a serious limitation in the treatment of human infections caused by clinically relevant Gram-positive bacteria including MRSA and VRE. 1 The most common mechanism of resistance in Enterococcus is mediated by mutational changes in the 23S rRNA region, which has been frequently associated with the use of linezolid in the treatment of human infections. 1, 2 Despite the overall low levels of linezolid resistance in EU and US health systems (,1% in 2015), 1, 3 an increasing number of Enterococcus with transferable genes mediating resistance to oxazolidinones has been observed in different settings, though they do not confer clinical resistance in all cases. 4 Besides mutations in 23S rRNA or ribosomal proteins, acquired mechanisms of resistance include: cfr gene variants V C The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
encoding a methyltransferase that modifies A2503 in bacterial 23S rRNA and confers resistance to oxazolidinones, phenicols, lincosamides, pleuromutilins and streptogramin A; and the optrA gene encoding an ABC transporter that confers cross-resistance to phenicols and oxazolidinones, including tedizolid. [5] [6] [7] Both have been located in plasmids carrying resistance to different antibiotic families and were already identified in staphylococci (cfr), Staphylococcus sciuri (optrA), Streptococcus suis (optrA and cfr) and Clostridium difficile (cfr), besides enterococci. 8 Recent surveys suggest that optrA can be more commonly distributed than expected. 8, 9 Among enterococci, the occurrence of optrA overcome that of cfr, having been identified in the EU (Denmark, Italy, Ireland, Germany, Poland), Asia (China, Korea, Malaysia, Taiwan) and America (USA, Colombia). 4, 6, 8, [10] [11] [12] [13] [14] [15] [16] [17] Plasmid-mediated oxazolidinone resistance has been strongly linked to animal sources where the use of phenicols might coselect resistance to both antibiotic families.
6,11 Still, we lack studies including the screening of all genes known to confer resistance to phenicols or oxazolidinones in enterococci and among disparate hosts. During an epidemiological survey assessing the diversity of genes conferring resistance to phenicols and/or oxazolidinones in enterococci from different sources and areas, we aimed to thoroughly characterize the first (to the best of our knowledge) optrAcarrying strains obtained from an African country. The complete sequence of the plasmid pAF379, on which optrA was located, is also provided.
Materials and methods

Bacterial strain collection
From 2578 well-characterized Enterococcus isolates obtained from different sources in Portugal (n " 2152), Tunisia (n " 377) and Angola (n " 49) over the last two decades (1996-2016), [18] [19] [20] [21] [22] [23] those expressing resistance to chloramphenicol (.16 mg/L, according to CLSI) 22 were selected for this study (n " 245). Portugal maintains commercial/travel relationships with African countries including Angola (a former Portuguese colony) and Tunisia (a major tourist destination for Portuguese citizens). Isolates were recovered from a variety of sources [hospitalized patients (n " 49), healthy humans (n " 40), hospital/urban wastewaters (n " 24), swine (n " 59), retail poultry meat (n " 40), aquaculture/supermarket rainbow trout (n " 23), cow milk (n " 9) and sheep faeces (n " 1)] in the three countries (Table S1 , available as Supplementary data at JAC Online). The 245 isolates mainly corresponded to Enterococcus faecalis (n " 159, 65%) followed by Enterococcus faecium (n " 31, 13%) and other Enterococcus species (n " 55, 22%). The collection mostly comprises unrelated isolates based on their PFGE profiles and/or MLST type, although several common strains previously identified in both human and animal isolates were also included (e.g. E. faecium ST148 found in healthy humans and retail poultry meat 19 or E. faecium ST1058 recovered from cow milk and hospitalized patients).
Screening of genes conferring resistance to phenicols and oxazolidinones
The presence of genes conferring resistance to phenicols was searched for by PCR and included: (i) the three most common chloramphenicol acetyltransferase (cat) variants described in Enterococcus [cat(pC221) (A-7), cat(pC223) (A-8) and cat(pC194) (A-9), as well as others detected in different Gram-positive bacteria [cat86 (A-6) from Bacillus, catS from Streptococcus (A-12), and catDP (A-11), catB (A-15) and catQ (A-16) from Clostridium], all belonging to the classical type A CATs; [24] [25] [26] and (ii) specific genes fexA and fexB encoding phenicol exporters, both previously associated with enterococci; 6, 27 The PCR screening of genes conferring resistance to both phenicols and oxazolidinones included: (i) both variants of the Cfr rRNA methyltransferase [cfr 28 and cfr(B) 7 ], and (ii) the ABC transporter gene optrA. 6 Amplified DNA fragments of optrA were purified using the NZYGelpure kit (NZYTech, Portugal) and sequenced. Location of fexA, fexB and/or optrA genes was assessed by hybridization of S1-digested genomic DNA. 29 Characterization of optrA-carrying strains
The clonal relationship of optrA-positive isolates was established by comparison of SmaI-PFGE profiles and/or MLST types (www.pubmlst.org). 21 The MICs of chloramphenicol and linezolid (both determined by broth microdilution) and tedizolid (determined by Etest) were interpreted according to epidemiological cut-offs (ECOFFs) (chloramphenicol and linezolid; www.eucast.org) or CLSI clinical breakpoints 30 when ECOFF values were not available (tedizolid). Antibiotic susceptibility was tested for 11 additional antibiotics (vancomycin, teicoplanin, ampicillin, ciprofloxacin, erythromycin, tetracycline, high-level gentamicin and streptomycin, nitrofurantoin, quinupristin/dalfopristin and tigecycline) and interpreted according to the same guidelines. E. faecalis ATCC 29212 and Staphylococcus aureus ATCC 29213 were used as control strains.
Transfer, stability and plasmid content of optrAcarrying strains
Transfer of optrA was tested by the filter-mating method at a 1:1 donor / recipient ratio using E. faecium BM4105, E. faecium GE1, E. faecalis JH2-2 and S. aureus 8325 as recipient strains (all resistant to rifampicin and fusidic acid; E. faecium GE1 also resistant to tetracycline). Transconjugants were recovered after incubation at 37 C for 24-48 h from plates of brain heart infusion agar supplemented with 30 mg/L rifampicin, 20 mg/L fusidic acid plus 2 mg/L linezolid or 10 mg/L chloramphenicol. Transconjugants were verified by SmaI-PFGE macrorestriction, presence of optrA and antibiotic susceptibility patterns. The stability of chloramphenicol, linezolid and tedizolid MIC values was assessed by 80 daily passages (500 bacterial generations) in Mueller-Hinton agar medium. Plasmid content (number and size) of WT and transconjugants was estimated by S1-PFGE followed by Southern blotting and hybridization with optrA and fexA gene probes as previously described. 29 
WGS
optrA-carrying isolates were selected for WGS. Genomic DNA was extracted from 1 mL of overnight cultures in brain heart infusion broth using a Wizard Genomic DNA Purification kit (Promega Corporation, Madison, WI, USA) according to the manufacturer's instructions. Genome sequencing was accomplished by an Illumina HiSeq platform, with average median depth of coverage 100% to obtain 5 million read pairs (2%125 bp), according to standard Illumina protocols performed at the GATC Biotech (Konstanz, Germany). Data were analysed using: FastQC (http://www.bioinformatics. babraham.ac.uk/projects/fastqc/) to test the quality of the raw and preprocessed data; SPAdes (v.3.9.0) for de novo assembling the paired-end reads; and QUAST (http://quast.bioinf.spbau.ru) for evaluating the quality of genome assembly. The assembled genomes were initially screened for genes encoding antibiotic resistance, virulence and MLST using in silico genomic tools (ResFinder 2.1, VirulenceFinder 1.5 and MLST 1.8 tools, respectively) available at the Center for Genomic Epidemiology (http://www. genomicepidemiology.org). Plasmid content associated with optrA was analysed using the contigs obtained by plasmidSPAdes that were annotated with the Prokka v1.12 tool 31 and the gene functions were classified according to the database of Clusters of Orthologous Groups of proteins (COGs) (http://www.ncbi.nlm.nih.gov/COG/). BLASTN and BLASTP analysis were performed to compare the contigs with known sequences of the NCBI database. PCR mapping targeting different combinations of optrA, fexA and Freitas et al.
IS1216 forward and reverse primers was used to confirm the location/ orientation of these genes. Easyfig v2.2.2 32 and Vector NTI v10.3.0 were used for drawing the plasmid schemes and comparisons. The Whole Genome Shotgun project of one of the E. faecalis containing optrA (E1379A) has been deposited at DDBJ/ENA/GenBank (Bioproject PRJNA386958) under the accession number NHNF00000000.
Results
Distribution of genes conferring resistance to phenicols and oxazolidinones
Among the 245 chloramphenicol-resistant isolates tested, 174 (71%), 7 (3%) and 2 (1%) carried genes encoding resistance to chloramphenicol (cat), phenicols (fexA, fexB) and phenicols ! oxazolidinones (optrA), respectively. Most isolates contained one cat gene (n " 174) and were identified in different enterococcal species from different hosts. The predominant cat variant was A-8 (n " 97, 40%), followed by cat(A-7) (n " 71, 29%) and cat(A-9) (n " 6, 2%). Figure S1 illustrates the distribution of the three cat variants among the different sources. Correspondence between any cat variant and the MIC values of chloramphenicol was not observed. fexB (n " 5, 2%) was identified in plasmids (30-120 kb) of four E. faecium isolates from cows and one Enterococcus durans from a retail trout. fexA and optrA co-occurred in two E. faecalis isolates from wastewaters in Tunisia. While cat genes were detected throughout the entire time frame of the study in the three countries, phenicol exporter genes such as fexA (Tunisia) or fexB (Tunisia and Portugal) were only identified after 2012, and optrA (Tunisia) in 2014. The presence of cat86, catDP, catB, catQ and catS genes was not detected in any strain, and 26% of the isolates (n " 65; n " 60/218 from Portugal, n " 1/23 from Tunisia and n " 4/4 from Angola) did not contain any of the tested genes. The screening of cfr and optrA was also performed in enterococci isolates susceptible to chloramphenicol (n " 382) from recent samples of hospitalized patients and animals without positive results (data not shown).
Phenotypic and molecular features of the optrA-positive isolates
The two optrA-carrying isolates corresponded to two ST86 E. faecalis exhibiting the same PFGE pattern. They were recovered during February 2014 from samples of the activated sludge and the terminal step of an urban wastewater treatment plant in Charguia, Tunisia. Sampling of wastewater samples was done during January 2014 and March 2015 in two urban wastewater treatment plants located in the north-east suburbs of Tunis city (La Charguia and El Menzah), Tunisia. The two wastewater treatment plants received urban municipal and hospital wastewater from distinct areas in Tunis city. Sixty-two samples were recovered at different points during the wastewater treatment process, at the entrance as influent, after the primary treatment, after the secondary treatment achieved by activated sludge, after the returned sludge and, lastly, at the terminal step of treatment of wastewater and water effluent. 
WGS analysis
By in silico analysis of assembled genomes, both E. faecalis were identified as ST86 and had identical profiles of putative virulence factors that included multiple adhesins and biofilm-associated genes [agg (aggregation substance), ace (collagen adhesin), srtA, gelE (gelatinase with protease activity), fsrB (gelE expression), efaAfs (cell wall adhesion expressed in serum), ebpA-ebpB-ebpC (endocarditis and biofilm-associated pili)], hyaluronidases (hylA, hylB), survival genes [elrA (leucine-rich protein A associated with macrophage persistence), tpx (thiol peroxidase for oxidative stress resistance)] and sex pheromone-associated genes (cad, coB1, cCF10, camE). OptrA amino acid sequences described in this work showed three changes (Met1Leu, Lys3Glu and Ile622Met) and one change (Met1Leu) when compared with that of E. faecalis pE439 (GenBank accession number KP399637; MIC of linezolid " 8 mg/L) and E. faecalis E016 (GenBank accession number KT862781; MIC of linezolid " 4 mg/L), respectively.
The optrA-carrying complete plasmid sequence detected in both isolates was deposited under the name of pAF379 (GenBank accession number NHNF00000000). The size of pAF379 (72918 bp) was compatible with that inferred from the S1-PFGE gel. Among the 75 ORFs identified in the plasmid, 35 encoded hypothetical proteins with no known function, while the products of the remaining 40 exhibited divergent identities with proteins with recognized functions, including antibiotic resistance [optrA, fexA, erm(A), spc], plasmid replication (repR, prgP) and conjugative transfer (T4SS, traG-traD, relaxase) (Figure 1a) . RepR of pAF379 was identical to the Rep 2 of pRE25-like plasmids previously observed in E. faecalis and E. faecium plasmids (e.g. pIP816, pVEF1, pEF1) of different origins. 29, 33 Upstream of repR is prgP, previously described in the pheromone-responsive pCF10 and the Inc18-like pRE25 E. faecalis plasmids as putatively involved in plasmid replication. Conjugation proteins included a relaxase sharing 100% amino acid identity to that of Chinese porcine nasal swab S. sciuri isolates (e.g. GenBank accession number KX447572) and 82% to that of a Clostridium sp. C105KSO15 isolate (GenBank accession number CUX62357), and putative conjugation proteins from the traG-traD family and the type IV secretory system (T4SS) displaying the highest amino acid homology with that from Clostridium sp. isolates (94% GenBank accession number CUX62380 and 93% GenBank accession number WP008395330, respectively). pAF379 corresponds to a novel plasmid chimera containing genes of disparate origins including an araC-NADH-spoVG-helicase region highly similar to that of a Chinese human E. faecalis E016, a relaxase and part of Tn558 including fexA previously found on an S. sciuri isolate of pigs 34 and Clostridium sp. and the Tn554 of S. aureus (GenBank accession number X03216) (Figure 1b) .
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Discussion
To the best of our knowledge, this study is the first to identify the optrA gene in the African continent, positioning it as currently disseminated in all continents. We further provide a snapshot of the distribution and diversity of genes encoding resistance to non-fluorinated phenicols (cat variants), non-fluorinated and fluorinated phenicols (fexA, fexB), and to both phenicols and oxazolidinones (cfr, optrA), in enterococci recovered from disparate hosts in different geographical areas.
In agreement with other studies, the predominant mechanism of chloramphenicol resistance was the production of modifying CAT enzymes. To date, the few studies searching for cat genes in enterococci mostly focused on cat(A-7), which has been detected in plasmids from different hosts (e.g. pRE25-E. faecalis, Freitas et al.
pIP501-Streptococcus agalactiae, pC221-S. aureus or pTZ12-Bacillus subtilis) and settings (human, food-production and wildlife animals, pets and environment). 24, 25, [35] [36] [37] We further document the strong association of cat(A-8), previously described in pRUM (E. faecium), pC223 (S. aureus), pK214 (Lactococcus lactis) or Listeria monocytogenes, with clinical and swine isolates, cat(A-7) mostly in healthy humans and poultry, and cat(A-9) (e.g. pC194-S. aureus or -S. suis) in animals. 24 To note, we often observe a link between clinical and swine enterococci (common MDR clones and vanA pRUM-like plasmids), 33 as well as between enterococci from healthy humans and poultry (identical aminoglycosideresistant clones or vanA Inc18-like plasmids), 19, 38 which suggest a kind of specificity between resistance genes and/or plasmid types and hosts/environments. To date, fexB has been detected in E. faecium, E. faecalis and Enterococcus hirae from humans and pigs, 6, 27 with this work representing the first (to the best of our knowledge) detection of fexB in E. durans from retail trout. The number of isolates (26%) lacking CAT or phenicol exporter genes suggests the presence of other resistance mechanisms as previously reported. 24 Given the widespread nature and inability of CAT-carrying enterococci to inactivate fluorinated phenicols, it is expected that florfenicol resistance genes arise in environments where florfenicol is authorized, as is the case of animal husbandry. Moreover, it can remain a long time in soils in the biologically active form. 39 A recent study associated fexA, fexB, cfr and optrA and the abundance of ISs (particularly IS1216) with the use of florfenicol in swine farms from China. 9 As with other antibiotics greatly used in livestock, florfenicol can exert selective pressure on environmental microorganisms and pose a significant risk to public health by the emergence of novel mechanisms of resistance to crucial last-resort antibiotics such as linezolid. 40, 41 This can be of particular concern for microorganisms such as enterococci, which are able to easily acquire and exchange antibiotic resistance genes with a wide range of species through a plethora of mobile genetic elements. fexA, fexB and optrA were indeed identified in more recent years, in this and other studies. 6, 27 First identified in China in E. faecalis and E. faecium isolates from at least 2005, 6 resistance to oxazolidinones mediated by optrA is now detected in enterococci, S. sciuri and S. suis of both humans and animals; optrA may be located in plasmids and/or chromosomes and confer variable levels of resistance (MIC of linezolid " 2-16 mg/L). 6, [8] [9] [10] [11] [12] [13] [14] 17, 42 Our isolates (MIC of linezolid " 4 mg/L) expressed an 'in vitro' susceptibility to linezolid according to EUCAST and were intermediate according to CLSI. Whether the three amino acid mutations in OptrA could partially contribute to the lower linezolid MIC observed (4 mg/L) in comparison with that of the original pE349 (8 mg/L), as postulated in other studies, 43, 44 remains unclear. Remarkably, these isolates would not alert clinicians according to the EUCAST ECOFF value (4 mg/L) for E. faecalis of linezolid.
The pAF379 represents the second fully sequenced optrA-carrying plasmid. 6 The ST86 E. faecalis isolates carried genes relevant in colonization, pathogenicity, biofilm formation and plasmid transfer also identified in other E. faecalis carrying optrA from poultry meat. 10, 45 Some of those genes (ace, gelE, agg and elrA) are enriched in clinically relevant and predominant vancomycin-resistant E. faecalis lineages. 46 ST86 has only been previously identified in clinical samples from Poland 47 and the USA (GenBank JAHF00000000), while the optrA-flanking region shared the highest similarity to that of human clinical E. faecalis from China (GenBank accession number KT862781) and the USA, 8 further indicating that the pAF379 plasmid identified in this study may have a clinical origin or is already disseminated throughout hospitals and the community.
The pAF379 plasmid corresponds to a unique chimera with relics of genetic elements from different Gram-positive bacteria. Despite the great variability observed in the different optrA genetic platforms identified to date in different hosts, they mostly share genes that are variably organized. 8, 48 The araC-optrA core region identified in this study seems to be conserved in E. faecalis isolates from humans, 48 and S. sciuri 42 or S. suis from swine containing optrA. 8 Its connection with Tn554 and Tn558 relics of different sizes has been commonly recognized and might be due to several independent integration events. Notably, radC, which is known to be the common integration site for transposons of the Tn554 family (e.g. Tn554, Tn558) in staphylococci and enterococci, 48 was found also flanking Tn554. Several ISs, including IS1216, were identified as in previous studies, surely accounting for the variety of optrA plasmids identified to date. 48 The finding of such ISs along with a variety of relics from different bacterial genera further highlight the wide possibilities of optrA-carrying plasmid mosaic constructions including a variety of genes from Firmicutes.
49
Chloramphenicol and florfenicol have already been identified as ubiquitous pollutants in waste-and seawater samples from Tunisia, including the region (Charguia) from where optrA-positive samples were obtained, 50 and it could facilitate the selection and persistence of strains carrying optrA, in areas where this resistance is increasingly reported. In fact, the global increase in the number of linezolid-non-susceptible enterococci carrying optrA is of concern and resembles a similar scenario of mcr in response to the use of colistin in animals. 51 Despite the considerable occurrence of enterococci carrying optrA with MIC values within the range of susceptible or intermediate susceptibility to linezolid and the unknown implications of this set-up in clinical practices, the need of an active surveillance on occurrence and spread of optrA is globally warranted. 
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